Arvaya Healthcare (BOM:524723) Cyclically Adjusted PB Ratio: (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524723 Arvaya Healthcare Ltd BOM:524723
57 GF Score
Price ₹122.00
GF Value ₹201.55
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Arvaya Healthcare Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Arvaya Healthcare  (BOM:524723) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Arvaya Healthcare Cyclically Adjusted PB Ratio Related Terms


Arvaya Healthcare Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Arvaya Healthcare's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvaya Healthcare Cyclically Adjusted PB Ratio Chart

Arvaya Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 1.16 1.32 1.33 3.29

Arvaya Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.29 0.00 3.29 0.00

BOM:524723 vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison

For the Medical Distribution subindustry, Arvaya Healthcare's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arvaya Healthcare Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arvaya Healthcare's Cyclically Adjusted PB Ratio falls into.


BOM:524723
57GF Score
Arvaya Healthcare Ltd BOM:524723
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvaya Healthcare Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Arvaya Healthcare's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Arvaya Healthcare's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Arvaya Healthcare Quarterly Data

Book Value per Share CPI Adj_Book
201609 15.462 105.961 24.421
201612 0.000 105.196 0.000
201703 14.927 105.196 23.748
201706 0.000 107.109 0.000
201709 14.962 109.021 22.968
201712 0.000 109.404 0.000
201803 14.549 109.786 22.178
201806 0.000 111.317 0.000
201809 14.348 115.142 20.855
201812 0.000 115.142 0.000
201903 14.280 118.202 20.218
201906 0.000 120.880 0.000
201909 14.087 123.175 19.140
201912 0.000 126.235 0.000
202003 14.101 124.705 18.924
202006 0.000 127.000 0.000
202009 13.993 130.118 17.998
202012 0.000 130.889 0.000
202103 13.805 131.771 17.533
202106 0.000 134.084 0.000
202109 13.442 135.847 16.560
202112 0.000 138.161 0.000
202203 13.177 138.822 15.886
202206 0.000 142.347 0.000
202209 12.775 144.661 14.779
202212 0.000 145.763 0.000
202303 11.697 146.865 13.329
202306 0.000 150.280 0.000
202309 11.499 151.492 12.703
202312 0.000 152.924 0.000
202403 11.306 153.035 12.364
202406 0.000 155.789 0.000
202409 10.664 157.882 11.304
202412 0.000 158.323 0.000
202503 11.760 157.552 12.492
202506 0.000 159.755 0.000
202509 11.454 162.289 11.812
202512 0.000 163.281 0.000
202603 12.474 164.272 12.708
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?

Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be undervalued. The current stock price of ₹122.00 is trading 39.5% below its estimated GF Value™ of ₹201.55. GuruFocus considers Arvaya Healthcare to be Possible Value Trap.

Key valuation signals for BOM:524723:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹201.55 vs. price of ₹122.00 (39.5% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arvaya Healthcare Business Description

Address G S Road, Nirvana Co Working spaces, Mezzanine Floor, Itag Plaza, ABC, Kamrup, Dispur, Gmc, Guwahati, AS, IND, 781005
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
57GF Score

Get the complete analysis for BOM:524723

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹122.00
Price
₹201.55
GF Value